Tumour‐associated angiogenesis in human colorectal cancer
- 12 September 2006
- journal article
- review article
- Published by Wiley in Colorectal Disease
- Vol. 9 (1), 3-14
- https://doi.org/10.1111/j.1463-1318.2006.01089.x
Abstract
Tumour angiogenesis is a critical step in the growth, metastatic spread and regrowth of colorectal cancer. Angiogenesis specific to tumour is a complicated process, the mechanisms of which remain unclear. Metastasis of colorectal cancer may result from passive entry into the circulation secondary to the effect of angiogenic factors. The survival and growth of colorectal tumour and thus their metastases are dependent on the balance of endogenous angiogenic and anti-angiogenic factors such that the outcome favours increased angiogenesis. Angiogenesis has become an attractive target for anticancer drug development, based on its important roles in tumour growth, invasion and metastasis. Several growth factors have been identified that regulate angiogenesis in colorectal cancer; the most important of these are vascular endothelial growth factors (VEGF), and of the several angiogenic factors, VEGF expression at the deepest invasive site of tumour is the most statistically significant prognostic indicator in advanced colorectal carcinoma. In this review article, we provide an overview on angiogenic factors and their receptors, and discuss the role of newly identified tumour endothelial markers (TEMs) that are involved in tumour-associated angiogenesis in colorectal cancer.Keywords
This publication has 63 references indexed in Scilit:
- TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domainsBiochemical and Biophysical Research Communications, 2005
- Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progressionEuropean Journal of Surgical Oncology, 2004
- TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI)Cancer Research, 2004
- Vascular Endothelial Growth Factor in Human Colon Cancer: Biology and Therapeutic ImplicationsThe Oncologist, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971